by Amy DuRoss | May 31, 2019
ASCO 2019 is here! With more cell and gene therapy advances in oncology, here are 10 important cell and gene therapy numbers we’re tracking in the fight against cancer.
by Vineti | May 30, 2019
In personalized therapies -- cell therapies, gene therapies, and neoantigen therapies -- a patient is not just the recipient of a drug product. The patient is the product.
by Marc Puich | May 15, 2019
Standing up the ecosystem your therapy will rely on requires a solid operational plan for how will your therapy move between your key stakeholders.
by Heidi Hagen | May 2, 2019
When it comes to cell and gene therapy, the four walls of your lab fall away fast.
by Marc Puich | April 24, 2019
There are many critical decisions to be made when moving a large-molecule biologic out of the lab into human trials.